NCT07195188Completed
Game-Based Education and Treatment Adherence in Type 2 Diabetes
The Effect of Game-based Education on Adherence to Treatment and Anxiety Level in Type 2 Diabetics Started on Insulin Therapy
Source: ClinicalTrials.gov · Last updated 26 Sept 2025
Brief summary (registry, in English)
The goal of this clinical trial is to learn if an education program can help lower anxiety and improve treatment follow-up in adults with type 2 diabetes. The main questions it aims to answer are: Does attending the education program lower anxiety levels? Does it help people better follow their diabetes treatment plan? Researchers will compare two groups: Education group: Participants who attend the program. Control group: Participants who do not attend the program. Participants will: Be randomly assigned to either the education group or the control group. Attend four weekly sessions, each lasting two hours, over one month (education group only). Complete surveys before and after the program, including the Beck Anxiety Scale (to measure anxiety) and the Patient Compliance Scale for Type 2 Diabetes Mellitus Treatment (to measure treatment follow-up).
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 72 (actual)
- First submitted
- 11 Sept 2025
- Start date
- 5 Apr 2024
- Primary completion date
- 3 May 2024
- Lead sponsor
- Izmir Tinaztepe University
- Diseases
- Type 2 diabetes
- NCT number
- NCT07195188
What you commit to
- Study type: Interventional
- Participants enrolled: 72
- From 5 Apr 2024 to the primary completion date, 3 May 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Being on insulin therapy for more than three months.
Age
- Age at diagnosis of diabetes is recent or less than 1 year.
- Not within the target age range, under 40 years or over 65 years.
Other
- Mental or psychological comorbidity.
- Refusing to participate in the research.
- Not attending one or more of the four training sessions during the research process.
Criteria the registry did not label
- nclusion Criteria:
- Age at diagnosis of diabetes is at least 1 year.
- The maximum duration of insulin treatment initiation is 3 months.
- Not having any mental problems.
- Between the ages of 40 and 65 years.
- Volunteering to participate in the study.
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Uşak Eğitim Ve Araştırma Hastanesi Coordinator of this site? Confirm its status | Uşak | Turkey (Türkiye) | Unknown status |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.